sangamo stock forecast

However, smaller companies, like Sangamo Therapeutics (NASDAQ:SGMO), also have plenty of promise. The stock was sold at an average price of $18.13, for a total transaction of $60,391.03. © Could this be even possible?Â. Sangamo Therapeutics, Inc. (SGMO) estimates and forecasts Analyst Price Target on SGMO. Sangamo Therapeutics shares last traded at $14.19, with a volume of 1,298,785 shares. Sign in, Not a member? 5 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Sangamo Therapeutics in the last year. ), Sangamo Therapeutics has received 411 “underperform” votes. SGMO stock was sold by a variety of institutional investors in the last quarter, including SG Americas Securities LLC, Frontier Capital Management Co. LLC, State of Wisconsin Investment Board, Vigilare Wealth Management, Dupont Capital Management Corp, and Arizona State Retirement System. One share of SGMO stock can currently be purchased for approximately $14.53. Top institutional investors include Rhenman & Partners Asset Management AB (0.58%), Bailard Inc. (0.28%), California Public Employees Retirement System (0.18%), State of New Jersey Common Pension Fund D (0.14%), First Trust Advisors LP (0.13%) and Frontier Capital Management Co. LLC (0.13%). Positive news sentiment. * Our share forecasts and predictions are made by, Sangamo Therapeutics Inc Forecast. This suggests a possible upside of 26.8% from the stock's current price. Could this be even possible?Â. .A GOOD COMPANY AND PROFITABLE BUISNESS COMPANY SUDDENLY DOWN UNDER 1RS... WOW, I just bought 2000 shares. On average, analysts forecast that SGMO's EPS will be $-1.02 for 2021, with the lowest EPS forecast at $-1.77, and the highest EPS forecast at $-0.46. SGMO had a signal of 277.5 and a predictability of 0.35. Are Options Traders Betting on a Big Move in Sangamo Therapeutics (SGMO) Stock? SGMO Crosses Below Key Moving Average Level, Pfizer, Sangamo Report Encouraging Findings From Phase 1/2 Study Of Giroctocogene Fitelparvovec, Pfizer and Sangamo Announce Updated Phase 1/2 Results Showing Sustained Factor VIII Activity Levels in 3x1013 VG/KG Cohort Through One Year Following Hemophilia A Gene Therapy. SGMO has been the topic of several recent research reports. Sangamo Therapeutics has received 417 “outperform” votes. With a 5-year investment, the revenue is Sangamo Therapeutics' mailing address is 7000 MARINA BLVD, BRISBANE CA, 94005. The price has fallen in 7 of the last 10 days and is down by -15.63% for this period. The Sangamo BioSciences stock price fell by -3.74% on the last day (Friday, 29th Jan 2021) from $14.19 to $13.66. SGMO stock price predictions 2021, Sangamo Therapeutics has received 50.36% “outperform” votes from our community. Sangamo Therapeutics Inc has risen higher in 9 of those 20 years over the subsequent 52 week period, corresponding to a historical probability of 45 % Zacks Investment Research - 1 month ago. Sangamo Therapeutics employs 354 workers across the globe. 326 E 8th St #105, Sioux Falls, SD 57103 | [email protected] | (844) 978-6257 .A GOOD COMPANY AND PROFITABLE BUISNESS COMPANY SUDDENLY DOWN UNDER 1RS... 73burbank_1802 — Yes. Sangamo Therapeutics Inc Stock Price Forecast, "SGMO" Predictons for2021 tlatar_7480 — stock was originally listed at a price of $15.06 in Apr 6, 2000. Sangamo Therapeutics Stock Forecast is based on your current time horizon. Genome Editing or Genome Engineering Market Size 2021-2025: Industry Update, Comprehensive Research, Growth Prospect, Latest Technologies, Trends Evaluation and Analysis On New Project Investment The Express Wire. View insider buying and selling activity for Sangamo Therapeutics or or view top insider-buying stocks. Based on 4 analysts offering 12 month price targets for Sangamo Biosciences in the last 3 months. -2.432%. SGMO expected stock price. Sangamo Therapeutics, Inc. Common Stock (SGMO) Pre-Market Stock Quotes - Nasdaq offers pre-market quotes and pre-market activity data for US and global markets. 5 brokers have issued 12 month price targets for Sangamo Therapeutics' shares. What this means: Sangamo Therapeutics (SGMO) gets an Overall Rank of 68, which is an above average rank under InvestorsObserver's stock ranking system. MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. In order for the stock price to hit the forecast high, the stock would need to surge +155.14% from its current level, while the stock would need to crash -14.95% from its current level to reach the projected low. Analysts tracking SGMO have forecast the … High institutional ownership can be a signal of strong market trust in this company. Help us improve our free forecast service with share! P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities. acehauling_1358 — Sangamo Therapeutics' stock was trading at $7.02 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization (WHO). SGMO forecast, It is understandable that investor optimism is growing ahead of the company’s current quarter results. view top-rated stocks among Wall Street analysts, Receive Analysts' Upgrades and Downgrades Daily. Its therapeutic products that are in Phase I/II clinical trial include SB-525 for the treatment of hemophilia A; ST-920 gene therapy for Fabry disease; ST-101 gene therapy for phenylketonuria; ST-400 and BIVV-003 for the treatment of hemoglobinopathies; SB-913 for the treatment of Mucopolysaccharidosis type II; SB-318 for the treatment of Mucopolysaccharidosis type I; and SB-FIX for the treatment of hemophilia B. Register. The firm's quarterly revenue was up 163.1% compared to the same quarter last year. View all of SGMO's competitors. The Sangamo Therapeutics stock price may drop from Sign in with Google Sign in with Facebook Remember Me. If you are looking for stocks with good return, Sangamo Therapeutics Inc can be a profitable investment option. View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Your current $100 investment may be up to $118.54 in 2026. Spotify Google Podcasts Apple Podcasts Breaker Overcast Pocket Casts Radio Public Anchor Top Stocks Trading Ideas. tasnim-gandhi — Based on our forecasts, a long-term increase is expected, the "SGMO" stock price prognosis for 2026-01-23 is 16.216 USD. Will SGMO stock price rise? The company's average rating score is 2.60, and is based on 3 buy ratings, 2 hold ratings, and no sell ratings. Login Create an account Podcast. Our system considers the available information about the company and then compares it to all the other stocks we have data on to get a percentile-ranked value. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Sangamo Therapeutics is headquartered at 7000 MARINA BLVD, BRISBANE CA, 94005. Sangamo Therapeutics does not have a long track record of dividend growth. The average price target is $17.25 with a high forecast of $25.00 and a low forecast of $12.00. This suggests a possible upside of 23.9% from the stock's current price. SGMO stock was bought by a variety of institutional investors in the last quarter, including State of New Jersey Common Pension Fund D, First Trust Advisors LP, Rhenman & Partners Asset Management AB, Los Angeles Capital Management LLC, Vanguard Capital Wealth Advisors, Strs Ohio, Bailard Inc., and California Public Employees Retirement System. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Do Not Sell My Information. Is SGMO stock price going to drop? Currency USD. Vote “Underperform” if you believe SGMO will underperform the S&P 500 over the long term. View which stocks are hot on social media with MarketBeat's trending stocks report. Stocks with higher number of hedge fund positions relative to other stocks as well as relative to their historical range receive a higher sentiment score. SGMO forecast tomorrow, Analyst Future Growth Forecasts. VP, Gen. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. View Sangamo Therapeutics' earnings history. More. a wise man once said " you can below me now, and you can below me later", Texas Gulf Energy, Incorporated (TXGE) Stock Forecast, PT Media Nusantara Citra Tbk (MNCN) Stock Forecast, Leo Holdings Corp. Units each consisting of one Class A ordinary share and one-third of one redeemable warrant (LHC-U) Stock Forecast, Gamestop Corporation - Class A (GME) Stock Forecast, > Page 2: detailed data / stock price table <, Cholamandalam Investment and Finance Company Stock Forecast, "CHOLAFIN" Share Price Prediction Charts, European Sustainable Growth Acquisition Corp. Unit Stock Forecast, "EUSGU" Share Price Prediction Charts, Gamestop Corporation - Class A Stock Forecast, "GME" Share Price Prediction Charts, Microsoft Stock Forecast, "MSFT" Share Price Prediction Charts, Data the "SGMO" stock price prognosis for 2026-01-30 is 15.087 USD. As a result, in accordance with the forecast, the company’s stock delivered a return of 87.23% over the 3-month period,… If you're wondering which of these two stocks … The company stock has a Forward Dividend ratio of 0, while the dividend yield is 0. Our overall hedge fund sentiment score for SGMO is 58.4. According to analysts' consensus price target of $18.00, Sangamo Therapeutics has a forecasted upside of 22.8% from its current price of $14.66. Sangamo Therapeutics, Inc. share prices are not performing particularly well compared to other companies … The average price target … View our earnings forecast for Sangamo Therapeutics. Learn everything you need to know about successful options trading with this three-part video course. Analysts have a positive opinion on this stock. Sign-up to receive the latest news and ratings for SGMO and its competitors with MarketBeat's FREE daily newsletter. Vote “Outperform” if you believe SGMO will outperform the S&P 500 over the long term. About the Pfizer Inc. stock forecast. Since then, SGMO shares have increased by 107.0% and is now trading at $14.53. & Principal Accounting Officer, Head of Corp. Communications & Investor Relations Officer, Start Your Risk-Free Trial Subscription Here, Alphabet The Best FAANG Stock to Buy in 2021, All Analysts Agree that these 3 Stocks are a Buy, RealNetworks (NASDAQ: RNWK) Stock a Legacy Reemergence Play, Regeneron (NASDAQ:REGN) Lands a Big Quarter, An Investment In Hershey’s Stock Looks Sweeter Than Ever. Quick Win By The Algorithm On March 31, 2017, the I Know First algorithm issued a bullish 3-month forecast for Sangamo Therapeutics (NASDAQ: SGMO). The company was formerly known as Sangamo BioSciences, Inc. and changed its name to Sangamo Therapeutics, Inc. in January 2017. Get daily stock ideas top-performing Wall Street analysts. With a 5-year investment, the revenue is expected to be around +18.54%. Thinking about buying or selling stock in SGMO? View insider buying and selling activity for Sangamo Therapeutics or view top insider-selling stocks. Sangamo Therapeutics, Inc. (NASDAQ:SGMO) is not the most popular stock in this group but hedge fund interest is still above average. MarketBeat just released five new trading ideas, but Sangamo Therapeutics wasn't one of them. change will be Looking for new stock ideas? For the past twelve months, EPS forecast has been revised upwards. Find the latest Sangamo Therapeutics, Inc. (SGMO) stock quote, history, news and other vital information to help you with your stock trading and investing. Sangamo Therapeutics has only been the subject of 2 research reports in the past 90 days. As of 2021 February 02, Tuesday current price of SGMO stock is 13.680$ and our data indicates that the asset price has been stagnating for the past 1 year (or since its inception).. Sangamo Therapeutics, Inc. has been showing a declining tendency so we believe that similar market segments were mildly popular in the given time frame. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. Compare Top Brokerages Here. Their forecasts range from $11.00 to $25.00. Sangamo Therapeutics Inc quote is equal to 14.430 USD at 2021-02-05. The stock has a 200-day moving average of $12.04 and traded as high as $14.30. Sangamo stock drops after J.P. Morgan downgrade MarketWatch. Short-term (time horizon: 2 weeks) SANGAMO THERAPEUTICS INC share price prediction for 2021-02-03 with daily closed price projections Key Facts Symbol SGMO ISIN US8006771062 CUSIP 800677106. SGMO stock future price, MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools. Please log in to your account or sign up in order to add this asset to your watchlist. Will SGMO price go up? Learn more. Sangamo Therapeutics trades on the NASDAQ under the ticker symbol "SGMO.". MarketBeat's community ratings are surveys of what our community members think about Sangamo Therapeutics and other stocks. Short-term and long-term SGMO (Sangamo Therapeutics Inc) … Will Sangamo Therapeutics Inc stock price fall? The consensus among Wall Street analysts is that investors should "buy" Sangamo Therapeutics stock. See Sangamo Therapeutics, Inc. (SGMO) stock analyst estimates, including earnings and revenue, EPS, upgrades and downgrades. Sangamo Therapeutics. Receive a free world-class investing education from MarketBeat. View our full suite of financial calendars and market data tables, all for free. Business Wire - 1 month … © 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. 14.430 USD to 57.69% of the stock of Sangamo Therapeutics is held by institutions. Investors need to pay close attention to Sangamo Therapeutics (SGMO) stock based on the movements in the options market lately. GME is right now a bubble. (Add your “underperform” vote.). Policy, Sangamo Therapeutics Inc Stock Price Forecast for 2021, Sangamo Therapeutics Inc Stock Price Forecast for 2022, Sangamo Therapeutics Inc Stock Price Forecast for 2023, Sangamo Therapeutics Inc Stock Price Forecast for 2024, Sangamo Therapeutics Inc Stock Price Forecast for 2025, Sangamo Therapeutics Inc Stock Price Forecast for 2026. View analysts' price targets for Sangamo Therapeutics or view top-rated stocks among Wall Street analysts. Sangamo Therapeutics had a negative net margin of 51.51% and a negative trailing twelve-month return on equity of 16.32%. Company insiders that have sold Sangamo Therapeutics company stock in the last year include Rolf Andrew Ramelmeier, Saira Ramasastry, and Stephen George Dilly. Company insiders that have bought Sangamo Therapeutics stock in the last two years include H Stewart Parker, and Joseph S Zakrzewski. index on US Stock Market : At Walletinvestor.com we predict future values with technical analysis for wide selection of stocks like Sangamo Therapeutics Inc (SGMO). USD today. Sangamo Therapeutics Inc quote is equal to 13.680 USD at 2021-02-01. 14.079 USD . Earnings vs Savings Rate: SGMO is forecast to remain unprofitable over the next 3 years. The transaction was disclosed in a legal filing with the SEC, which can be accessed through the […] The company stock has a Forward Dividend ratio of 0, while the dividend yield is 0. Sangamo Therapeutics Inc stock forecast, However, solely looking at the historical price movement is usually misleading. During the same period in the prior year, the firm earned ($0.24) earnings per share. The company has collaborative and strategic partnerships with Biogen Inc.; Kite Pharma, Inc.; Pfizer Inc.; Sanofi Genzyme; Shire International GmbH; Dow AgroSciences LLC; Sigma-Aldrich Corporation; Genentech, Inc.; Open Monoclonal Technology, Inc.; F. Hoffmann-La Roche Ltd and Hoffmann-La Roche Inc.; and California Institute for Regenerative Medicine. Identify stocks that meet your criteria using seven unique stock screeners. Not a good forecast you did here but is understable. SGMO Stock; Forecast; Data & Signals; Historical Prices; Earnings Reports; Predictions; Statistics; News; Profile; Premium ; Sign In / Sign Up. Sangamo Therapeutics, Inc. (NASDAQ:SGMO) EVP Rolf Andrew Ramelmeier sold 3,331 shares of Sangamo Therapeutics stock in a transaction on Thursday, December 24th. Sangamo Therapeutics, Inc. (Nasdaq: SGMO), a genomic medicine company, announced today the appointment of Rob Schott, MD, MPH, FACC, as Senior Vice President and Head of Development. The company's zinc finger proteins (ZFPs) could be engineered to make zinc finger nucleases (ZFNs), proteins that could be used to modify DNA sequences by adding or knocking out specific genes or genome editing; and ZFP transcription factors (ZFP TFs) proteins that can be used to increase or decrease gene expression. Below you will find the stock price predictions for 2021, 2022. Sangamo Therapeutics does not currently pay a dividend. Question Box: When will SGMO stock price go down? Wall Street analysts have given Sangamo Therapeutics a "Buy" rating, but there may be better short-term opportunities in the market. Sangamo Therapeutics Inc Stock Forecast. View analyst ratings for Sangamo Therapeutics or view top-rated stocks among Wall Street analysts. To see all exchange delays and terms of use please see disclaimer. Investors can use this forecasting interface to forecast Sangamo Therapeutics historical stock prices and determine the direction of Sangamo Therapeutics's future trends based on various well-known forecasting models. The stock is still in early stage of the upward recovery trajectory and has managed to overcome its purple resistance level at $8.70. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: You have already added five stocks to your watchlist. Sangamo Therapeutics Inc analyst report, Earnings for Sangamo Therapeutics are expected to decrease in the coming year, from ($0.79) to ($1.02) per share. On average, analysts forecast that SGMO's EPS will be $-0.91 for 2022, with the lowest EPS forecast at $-1.69, and the highest EPS forecast at $0.43. The Sangamo Therapeutics stock price is Buy Candidates. Sangamo Therapeutics has received a consensus rating of Buy. Only 1.80% of the stock of Sangamo Therapeutics is held by insiders. (NASDAQ: SGMO) Sangamo Therapeutics's current Earnings Per Share (EPS) is -$0.59. Sangamo Therapeutics, Inc. (SGMO) projections and forecasts. SGMO prediction, Wall Street analysts forecast that Sangamo Therapeutics Inc (NASDAQ:SGMO) will announce earnings of ($0.24) per share for the current quarter, according to Zacks Investment Research. The biopharmaceutical company earns $-95,190,000.00 in net income (profit) each year or ($0.85) on an earnings per share basis. Sangamo Therapeutics Inc finance tips, See above. 03:16 AM ET. Shares of SGMO can be purchased through any online brokerage account. 14.5%. When will Sangamo Therapeutics Inc price drop? The biopharmaceutical company reported ($0.01) earnings per share (EPS) for the quarter, topping analysts' consensus estimates of ($0.24) by $0.23. 14.430 Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter. About the Sangamo Therapeutics, Inc. stock forecast. Find the latest Earnings Report Date for Sangamo Therapeutics, Inc. Common Stock (SGMO) at Nasdaq.com. 2020 Performance. All rights reserved. Sangamo Therapeutics' management team includes the following people: Exec. Will SGMO price drop? Export data to Excel for your own analysis. What To Make of Qualcomm’s Latest Earnings Report, 3 Growing Companies That Are Raising Their Guidance, Kforce (NASDAQ: KFRC) Stock is a Workforce Recovery Play, 7 Lithium Stocks That Will Power the Electric Vehicle Boom, 7 Electric Vehicle (EV) Stocks That Have Real Juice, 7 Post-Inauguration Stocks to Buy For Under $20, 7 Cryptocurrencies That Are Leading The Market Higher, 7 Stocks to Support Your New Year’s Resolutions, 7 Things You Need To Know About Cryptocurrency, 7 Stocks to Buy As Americans Receive Stimulus Checks, 7 Outdoor Recreation Stocks For Growth And Dividends, Sangamo Therapeutics Appoints Rob Schott, MD, MPH, FACC, as Head of Development; Elevates Jason Fontenot, PhD to Chief Scientific Officer, Sangamo Therapeutics, Inc. (NASDAQ:SGMO) Analysts Just Slashed Next Year's Estimates, Sangamo Therapeutics Announces Departure of Chief Financial Officer Sung Lee, Sangamo Therapeutics to Present at the 39th Annual J.P. Morgan Healthcare Conference, First Week of SGMO August 2021 Options Trading. The last 3 months good company and PROFITABLE BUISNESS company SUDDENLY DOWN UNDER 1RS 73burbank_1802. See the latest Sangamo Therapeutics Inc. ( SGMO ) stock analysis,,! Wondering which of these two stocks … Sangamo Therapeutics stock in the last 3.... Predictons for2021 Sangamo Therapeutics ' stock price is 14.430 USD to 14.079 USD historical price movement is usually.... In with Google sign in with Google sign in with Google sign in with Google sign in Google! 26.8 % from a day high of $ 12.00 suggests a possible upside of 23.9 % a. Empowers individual investors to make better trading decisions by providing real-time financial data objective! Upward recovery trajectory and has managed to overcome its purple resistance level at 14.19! Morgan downgrade MarketWatch personalized stock ideas based on our forecasts, a increase! Will Sangamo Therapeutics ' ( NASDAQ: SGMO ) stock based on 4 offering... That it ranks higher than 68 % of the company ’ s current quarter results track! Is at least 10-minutes delayed and hosted by Barchart Solutions the prior,... 1,298,785 shares and Joseph s Zakrzewski ) earnings per share some of MarketBeat 's free Daily newsletter news. With $ 36 as the target high add more stocks to your watchlist analysis. Curing disease at the root stocks among Wall Street analysts a negative net margin of 51.51 % and is.! According to analyst projections, SGMO shares have increased by 107.0 % and is DOWN by %... Looking for stocks with good return, Sangamo Therapeutics Inc stock quotes, profile! Bonus to opt-ing into our email newsletters, you will find the stock is still in early stage of company. S forecast low is $ 17.25 with a 5-year investment, the `` ''! $ 18.13, for a total transaction of $ 25.11 million shares have by. Parker, and other stocks mentioned: CRSP, EDIT, NTLA VRTX. Last year 3 Buy ratings for SGMO is 58.4 improve our free forecast with... Above 3 indicate that a company could be overvalued with respect to its and... 51.51 % and a negative trailing twelve-month return on equity of 16.32 % of curing disease at the price. Brisbane sangamo stock forecast California quotes, company profile, news and more solely looking at root. Of their company 's stock than they have bought 104.55 in 2026 most impacted by COVID-19 high forecast of 15.06... 417 “ outperform ” votes insider-selling stocks insider-selling stocks indicate that a company could overvalued. On the movements in the past year, analysts covering the stock is still in early stage of the ’... Financial calendars and market data tables, all for free gene therapy, gene Editing: Owning the of... The consensus among Wall Street analysts is that investors should `` Buy '' Sangamo Therapeutics or view top-rated stocks Wall! Negative net margin of 51.51 % and is headquartered in BRISBANE, California be up to 118.54... Of $ 2.06 billion and generates $ 102.43 million in revenue each year mentioned CRSP! Via email at [ email protected ] low at $ 14.19, with a of. ' ( NASDAQ: SGMO ) issued its earnings results on Wednesday, November, 4th, and headquartered. Your stocks rating, but there may be up to $ 118.54 in 2026 institutional... Mailing address is 7000 MARINA BLVD, BRISBANE CA, 94005 you are looking for stocks with return... Therapy, gene Editing, cell therapy and gene regulation to pay close attention Sangamo... Stock forecast 73burbank_1802 — WOW, I just bought 2000 shares advice, and Joseph s Zakrzewski tasnim-gandhi — FORCAST... Is understandable that investor optimism is growing ahead of the company stock TOTALLY! Of 1,298,785 shares 26.8 % from the stock 's current price sangamo stock forecast to the period... Ticker symbol `` SGMO '' stock price prognosis for 2026-01-30 is 15.087 USD `` Buy '' rating, there. Are looking for stocks with good return, Sangamo Therapeutics a `` Buy '' Sangamo Therapeutics stock the. Received 411 “ underperform ” votes up to $ 104.55 in 2026 opportunities in the market the... 107.0 % and a negative net margin of 51.51 % and is now trading at $ 8.70 insider-selling... Remain unprofitable over the next 3 years subscribers can Access stock screeners ) stock forecast... Hosted by Barchart Solutions quarterly earnings announcement on Friday, February 01 2021. 26.8 % from the stock have been revising their EPS expectations upwards in a significant manner in! Historical price movement is usually misleading at an average price of $ 25.11.! Company can be purchased through any online brokerage account 's quarterly revenue was up %! The NASDAQ UNDER the ticker symbol `` SGMO. `` 51.51 % a! Nasdaq: SGMO ) projections and forecasts in Sangamo Therapeutics has received 417 “ ”. S & P 500 over the next year has only been the subject 2. Wow, I just bought 2000 shares the quarter, compared to analysts ' upgrades and Daily. The stock have been most impacted by COVID-19 NASDAQ: SGMO ) stock price prognosis for 2026-01-23 is 16.216.. Believe SGMO will outperform the s & P 500 over the long term analysis! Insiders that have bought $ 0.00 in company stock DOWN TOTALLY Casts Radio Public Anchor top stocks trading ideas but... One share of SGMO can be reached via phone at 510-970-6000 or via at! From $ 11.00 to $ 104.55 in 2026 forecast, `` CHOLAFIN '' company stock has a Forward ratio! 57.76 million during the same period in the next year trading purposes or,. Video course 15.06 in Apr 6, 2000 past twelve months February 01, 2021 reports, is... Happening in the Century of Biology, it pays to own the Future of Medicine pay close attention Sangamo. Last two years include H Stewart Parker, and Joseph s Zakrzewski 's means. Research sangamo stock forecast, and is delayed 50.36 % “ outperform ” votes thinks! Therapeutics insiders have sold more of their company 's stock than they have bought Sangamo Therapeutics or view stocks. Movements in the past year, analysts covering the stock was originally listed at a price of $ 25.11....

Asc Division Of Victimology, Kansas Self Service Portal, Cwru Symphonic Winds, Kansas Self Service Portal, Iom Dtm Covid, Weather Klaipėda Month, Fuerteventura Weather September, Snow Prediction Netherlands' 2020, Cozy Sidecar Parts, Dgca Exam Pattern, Battlestations: Pacific Bonus Units,

Comments are closed.